695 related articles for article (PubMed ID: 30414316)
1. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
[TBL] [Abstract][Full Text] [Related]
6. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
Ogata M
Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
[TBL] [Abstract][Full Text] [Related]
7. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
[TBL] [Abstract][Full Text] [Related]
9. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
Mori Y; Miyamoto T; Nagafuji K; Kamezaki K; Yamamoto A; Saito N; Kato K; Takenaka K; Iwasaki H; Harada N; Abe Y; Teshima T; Akashi K
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1596-602. PubMed ID: 20685258
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
Tamaki H; Ikegame K; Yoshihara S; Kaida K; Yoshihara K; Inoue T; Kato R; Nakata J; Fujioka T; Soma T; Okada M; Ogawa H
Transpl Infect Dis; 2019 Jun; 21(3):e13073. PubMed ID: 30875143
[TBL] [Abstract][Full Text] [Related]
11. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
[TBL] [Abstract][Full Text] [Related]
13. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients.
Kurata K; Yakushijin K; Okamura A; Yamamori M; Ichikawa H; Sakai R; Mizutani Y; Kakiuchi S; Miyata Y; Kitao A; Kawamoto S; Matsuoka H; Murayama T; Minami H
Cancer Chemother Pharmacol; 2018 May; 81(5):839-846. PubMed ID: 29511796
[TBL] [Abstract][Full Text] [Related]
16. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
[TBL] [Abstract][Full Text] [Related]
17. Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation.
Morita D; Hirabayashi K; Katsuyama Y; Morokawa H; Motobayashi M; Kurata T; Shigemura T; Tanaka M; Inaba Y; Koike K; Nakazawa Y
Transpl Infect Dis; 2016 Oct; 18(5):773-776. PubMed ID: 27459097
[TBL] [Abstract][Full Text] [Related]
18. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
19. Unique Challenges to Diagnosing Human Herpesvirus-6 (HHV-6) Encephalitis Following Post-Hematopoietic Stem Cell Transplant: A Case and Brief Review.
Zhu H; Ali A; Woan KV; Tam E; Yaghmour G; Flores A; Chaudhary P
Cell Transplant; 2022; 31():9636897221119734. PubMed ID: 36927092
[TBL] [Abstract][Full Text] [Related]
20. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
